Search clinical trials for: acromegaly

Total 195 results

Immunwork, Inc.

Not yet recruiting

A Phase 1 Study of TE-8214 Solution in Healthy Volunteers

Acromegaly

Australia
IRCCS San Raffaele
Istituto Auxologico Italiano; Fondazione Policlinico Universitario Campus Bio-Medico

Recruiting

Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess. Cross-sectional and Prospective Study

Acromegaly | Bone Fracture

Italy
IRCCS San Raffaele

Not yet recruiting

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Pituitary Adenoma | Acromegaly | Hypopituitarism | Adiposity | Cushing Syndrome | Endocrine Disorders
Ipsen

Not yet recruiting

A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly (BackSOM)

Acromegaly | Gastro-enteropancreatic Neuroendocrine Tumor
Istituto Auxologico Italiano
Politecnico di Milano

Recruiting

Effects of Therapies in the Acromegaly Disease: Acral Morpho-functional Study (ACROMORFO)

Acromegaly

Italy
Christian Alexander H Rosendal
Pfizer; Ipsen

Recruiting

Acromegaly: Balance, Falls and Fracture Risk

Acromegaly

Denmark
Cedars-Sinai Medical Center

Recruiting

Diet in the Management of Acromegaly

Acromegaly

United States
Azienda Ospedaliero Universitaria Maggiore della...

Not yet recruiting

Hypoproteic Diet in Acromegaly (IpoProAcro)

Acromegaly

Italy
University Hospital, Strasbourg, France

Recruiting

Somatostatin Analogues in the Treatment of Relapsing GH Pituitary Adenomas After Surgery (STOP-SST)

Acromegaly

France
Pfizer

Recruiting

Korean Regulatory Post Marketing Surveillance for Somavert

Acromegaly

Korea, Republic of
University Hospital, Montpellier

Recruiting

Micromegaly and Discrepancy Between Growth Hormone and IGF1 at the Diagnosis and Follow-up of Acromegalic Patients

Acromegaly

France
Eunice Kennedy Shriver National Institute of Child...

Recruiting

Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess

Pituitary Disease

United States
Seoul National University Hospital

Recruiting

Sleep Apnea in Acromegaly After Surgery

Sleep Apnea

Korea, Republic of
Seoul National University Hospital

Recruiting

Seoul National University Pituitary Disease Cohort Study (SNU-PIT)

Acromegaly | Cushing's Disease | Pituitary Tumor | Prolactinoma | Pituitary Disease | Central Diabetes Insipidus | Pituitary Incidentaloma | Pituitary Stalk Compression Hyperprolactinaemia

Korea, Republic of
Samsung Medical Center

Not yet recruiting

Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma (MERGE)

Acromegaly Due to Pituitary Adenoma

Korea, Republic of
Ginkgo Leaf Center for Rare Disorders

Recruiting

The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research

Acromegaly

China
National Taiwan University Hospital

Recruiting

Developing a Simple Recognition System of Acromegaly

Acromegaly

Taiwan
Barts & The London NHS Trust

Recruiting

Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA

Acromegaly | Gigantism | Familial Isolated Pituitary Adenoma | FIPA | Pituitary Adenoma Predisposition | PAP

United Kingdom
Eunice Kennedy Shriver National Institute of Child...

Recruiting

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Cushing Disease | Prolactinoma | Panhypopituitarism | Gigantism/Acromegaly

United States
Cedars-Sinai Medical Center

Active, not recruiting

Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly

Acromegaly

United States
Camurus AB

Active, not recruiting

A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

Acromegaly

United States, Spain, United Kingdom, Germany, Russian Federation, Greece, Hungary, Italy, Poland, Turkey, Serbia
Ipsen

Active, not recruiting

Real-World Study (RWS) of Lanreotide Autogel (LAN) for the Treatment of Patients With Acromegaly in China

Acromegaly

China
Crinetics Pharmaceuticals Inc.

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-1)

Acromegaly

United States, Argentina, Belgium, Brazil, Bulgaria, France, Hungary, Israel, Italy, Peru, Poland, Russian Federation, Serbia, United Kingdom
Debiopharm International SA

Active, not recruiting

A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) (OXTEND-01)

Acromegaly | GEP-NET

United Kingdom, France, Spain, Italy, Poland, Denmark, Germany, Israel
Crinetics Pharmaceuticals Inc.

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) (PATHFNDR-2)

Acromegaly

United States, Argentina, Brazil, Bulgaria, France, Hungary, Israel, Italy, Poland, United Kingdom, China, Germany, Greece, India, Spain
Camurus AB

Completed

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly (ACROINNOVA 1)

Acromegaly

United States, Spain, United Kingdom, Germany, Russian Federation, Greece, Hungary, Italy, Poland, Turkey
NRG Oncology
National Cancer Institute (NCI)

Suspended

Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer (NADIR)

Prostate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8

Canada, United States
University of Alberta

Active, not recruiting

Long Term Outcome Study in Patients With Pituitary Disorders

Pituitary Neoplasms | Pituitary Diseases
Crinetics Pharmaceuticals Inc.

Active, not recruiting

A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)

Acromegaly

United States, Hungary, Brazil, Greece, Serbia, United Kingdom
University of Aarhus

Active, not recruiting

ACRODAT Prospective Evaluation Study

Acromegaly

Denmark
University of Copenhagen
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaborators

Completed

Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor (GA-9)

Acromegaly Due to Pituitary Adenoma

Denmark
Haukeland University Hospital
Karolinska Institutet; University Hospitals Bristol and Weston NHS Foundation... and other collaborators

Completed

Dynamic Hormone Diagnostics in Endocrine Disease (ultradian)

Congenital Adrenal Hyperplasia | Acromegaly | Growth Hormone Deficiency | Cushing Syndrome | Primary Hyperaldosteronism | Adrenal Insufficiency

Norway, Sweden, Greece, United Kingdom
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Single-dose Study of Octreotide Injection in Healthy Adult Subjects

Acromegaly

China
Ohio State University
Corr-Jensen, LLC provided some of the study oil from Arista Industries, Inc

Completed

Healthy Oils for Women (HOW Study) (HOW)

Metabolic Syndrome

United States
Pfizer

Completed

Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment Plan

Acromegaly
University of Roma La Sapienza

Completed

PegvisOMant and the Immune SystEm (PROMISE)

Acromegaly

Italy
Ionis Pharmaceuticals, Inc.

Completed

A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly

Acromegaly

United States, Hungary, Serbia, Estonia, Italy, Latvia, Lithuania, Poland, Romania, Russian Federation
Andrea M. Isidori

Completed

Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy (SUM)

Acromegaly Cardiomyopathy

Italy
Assistance Publique Hopitaux De Marseille

Completed

Late Effects of Radiosurgery on Acromegaly Study (LateRAc)

Acromegaly

France
Ionis Pharmaceuticals, Inc.

Completed

Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

Acromegaly

United States, Serbia, Poland, Russian Federation, Hungary, Lithuania
Ipsen

Withdrawn

Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China

Acromegaly
Fundació Institut de Recerca de l'Hospital de la...
A.O. Ospedale Papa Giovanni XXIII; Consorcio Centro de Investigación Biomédica...

Completed

Effects of Mindfulness Therapy in Patients With Acromegaly and Cushing

Patient Satisfaction

Spain
Cedars-Sinai Medical Center

Terminated

Acromegaly Combination Treatment Study

Acromegaly

United States
University Hospital, Ghent
Pfizer

Completed

Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?

Acromegaly

Belgium
Ionis Pharmaceuticals, Inc.

Completed

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

Acromegaly

United States, Hungary, Serbia, Romania, Russian Federation, Lithuania, Poland
Azidus Brasil

Suspended

Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ®

Acromegaly

Brazil
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Icahn...

Active, not recruiting

A Prospective Study of Outcome After Therapy for Acromegaly

Acromegaly

United States
Columbia University
Ipsen

Active, not recruiting

Treatment Patterns and Treatment Outcomes for Acromegaly

Acromegaly

United States
Ipsen

Completed

Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma (PRIMARYS)

Acromegaly

Netherlands, Germany, France, United Kingdom, Turkey, Belgium, Czechia, Finland, Italy
Ipsen

Completed

Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients

Acromegaly

Germany, Netherlands, Sweden, Czechia, Denmark, France, Greece, Italy, Spain, United Kingdom

Search clinical trials for: acromegaly

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations